|
ZNHIT3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.594000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.097200E-03 |
| Normal-vs-Stage2 |
2.828600E-01 |
| Normal-vs-Stage3 |
5.153800E-01 |
| Normal-vs-Stage4 |
5.980400E-01 |
| Stage1-vs-Stage2 |
3.848200E-01 |
| Stage1-vs-Stage3 |
5.601000E-04 |
| Stage1-vs-Stage4 |
6.554500E-02 |
| Stage2-vs-Stage3 |
1.146430E-01 |
| Stage2-vs-Stage4 |
5.493400E-01 |
| Stage3-vs-Stage4 |
2.822200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.425900E-02 |
| Normal-vs-AfricanAmerican |
2.641800E-01 |
| Normal-vs-Asian |
3.566600E-01 |
| Caucasian-vs-AfricanAmerican |
8.513000E-01 |
| Caucasian-vs-Asian |
3.964800E-01 |
| AfricanAmerican-vs-Asian |
5.232600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.508300E-02 |
| Normal-vs-Female |
6.474200E-02 |
| Male-vs-Female |
7.435000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.763800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.832400E-02 |
| Normal-vs-Age(61-80Yrs) |
5.599900E-02 |
| Normal-vs-Age(81-100Yrs) |
8.142200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.857400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.831400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.672400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.787200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.911000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.980600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.095900E-02 |
| Normal-vs-Grade 2 |
1.284860E-03 |
| Normal-vs-Grade 3 |
2.991000E-01 |
| Normal-vs-Grade 4 |
3.109200E-01 |
| Grade 1-vs-Grade 2 |
4.357800E-01 |
| Grade 1-vs-Grade 3 |
1.437790E-01 |
| Grade 1-vs-Grade 4 |
4.625800E-02 |
| Grade 2-vs-Grade 3 |
2.167700E-02 |
| Grade 2-vs-Grade 4 |
1.558650E-03 |
| Grade 3-vs-Grade 4 |
6.072000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.07899999999928E-05 |
| Normal-vs-ccB subtype |
4.795600E-01 |
| ccA subtype-vs-ccB subtype |
6.5575999996792E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.956100E-02 |
| Normal-vs-N1 |
9.815800E-01 |
| N0-vs-N1 |
4.150400E-01 |
|
|
